Skip to content- Sources: primary, discussion
- Summary: Anthropic describes work with Generate Biomedicines, Divergence Labs, BigHat Biosciences, Enveda, The Column Group and Bristol Myers Squibb, each with a technical report. At Enveda, Claude caught all 11 issues human reviewers found in 1,061 pages of manufacturing records plus seven they missed, and Anthropic acquired Mithril Medicine to run its own muscular dystrophy programs. The work is mostly preclinical.
- Why it matters: It gives mechanism-level accounts of agents wired into lab data systems and regulatory paperwork, not only molecule generation.